Table 3.
ELISA Results by Group
| Group | Patients, No. | Positive by AgB1, No. (%) |
Positive by AgB2, No. (%) |
P Value |
|---|---|---|---|---|
| Active-transitional | ||||
| Total | 94 | 80 (85.1) | 79 (84.0) | >.99 |
| CE1 | 7 | 7 (100.0) | 5 (71.4) | .50 |
| CE2 | 9 | 7 (77.8) | 8 (88.9) | >.99 |
| CE3a | 27 | 22 (81.5) | 25 (92.6) | .38 |
| CE3b | 51 | 44 (86.3) | 41 (80.4) | .58 |
| Inactive | ||||
| Total | 54 | 17 (31.5) | 32 (59.3) | <.001a |
| CE4 | 36 | 15 (41.7) | 25 (69.4) | .01a |
| CE5 | 18 | 2 (11.1) | 7 (38.9) | .06 |
| Postsurgical | 25 | 11 (44.0) | 14 (56.0) | .25 |
| Healthy controls | 249 | 7 (2.8) | 40 (16.1) | <.001a |
Abbreviations: AgB1, antigen B1; AgB2, antigen B2; ELISA, enzyme-linked immunosorbent assay.
a
Statistically significant difference (McNemar test).